Royal Bank of Canada’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Royal Bank of Canada’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,300	Closed	-$115K	–	7376
2019 Q1	$115K	Buy	+3,300	New	+$95.2K	﹤0.01%	4697
2015 Q1	–	Sell	-6,000	Closed	-$170K	–	6521
2014 Q4	$170K	Buy	+6,000	New	+$167K	﹤0.01%	4451

Royal Bank of Canada's PTLA Position: Q3 2020 in Review

Royal Bank of Canada sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 301,185 shares — an estimated $5.42M sold.

Royal Bank of Canada first reported a position in PTLA in Q3 2013 and held it in 26 quarters. The position peaked at $5.42M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Royal Bank of Canada reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Royal Bank of Canada sold 301,185 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $5.42M.
Royal Bank of Canada first reported a position in Portola Pharmaceuticals, Inc. in Q3 2013 and held it in 26 quarters.
Royal Bank of Canada's Portola Pharmaceuticals, Inc. position peaked at $5.42M in Q2 2020.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Royal Bank of Canada's 13F filing for Q3 2020, filed 16 Nov 2020.